Literature DB >> 18182460

Human antimicrobial proteins effectors of innate immunity.

Jürgen Harder1, Regine Gläser, Jens-Michael Schröder.   

Abstract

We live in a world populated by an enormous number of micro-organisms. This necessitates the existence of highly effective mechanisms to control microbial growth. Through many research efforts, a chemical defense system based on the production of antimicrobial proteins (AMPs) has been identified. AMPs are endogenous, small proteins exhibiting antimicrobial activity against a wide variety of micro-organisms. The wide distribution of these molecules in the plant and animal kingdom reflects their biological significance. Various human AMPs show a potent effect on pathogenic micro-organisms including antibiotic-resistant bacteria. Thus, there is great interest in understanding the role of AMPs within innate immunity and evaluating their use and/or specific induction to fend off infections. In this review, we provide an overview of the characteristics of human AMPs and discuss examples where AMPs may be involved in the pathogenesis of infectious and inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18182460     DOI: 10.1177/0968051907088275

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  27 in total

1.  Transmigration across activated endothelium induces transcriptional changes, inhibits apoptosis, and decreases antimicrobial protein expression in human monocytes.

Authors:  Marcie R Williams; Yumiko Sakurai; Susu M Zughaier; Suzanne G Eskin; Larry V McIntire
Journal:  J Leukoc Biol       Date:  2009-08-25       Impact factor: 4.962

Review 2.  Cholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and disease.

Authors:  Brenda J Curtis; Katherine A Radek
Journal:  J Invest Dermatol       Date:  2011-09-15       Impact factor: 8.551

Review 3.  [The role of the innate immune system in atopic dermatitis].

Authors:  T Volz; S Kaesler; Y Skabytska; T Biedermann
Journal:  Hautarzt       Date:  2015-02       Impact factor: 0.751

4.  [The skin's own antibiotics. Important features of antimicrobial peptides for clinical practice].

Authors:  J Cordes; M Wittersheim; J Harder; R Gläser
Journal:  Hautarzt       Date:  2014-01       Impact factor: 0.751

5.  Decreased susceptibility of Staphylococcus aureus small-colony variants toward human antimicrobial peptides.

Authors:  Regine Gläser; Karsten Becker; Christof von Eiff; Ulf Meyer-Hoffert; Jürgen Harder
Journal:  J Invest Dermatol       Date:  2014-04-09       Impact factor: 8.551

6.  Subclinical infection can be an initiator of inflammaging leading to degenerative disk disease: evidence from host-defense response mechanisms.

Authors:  S Rajasekaran; Tangavel Chitraa; S Dilip Chand Raja; M Raveendran; Nayagam Sharon Miracle; K S Sri Vijayanand; Shetty Ajoy Prasad; Kanna Rishi Mugesh
Journal:  Eur Spine J       Date:  2021-04-09       Impact factor: 3.134

7.  Proteolysis of human thrombin generates novel host defense peptides.

Authors:  Praveen Papareddy; Victoria Rydengård; Mukesh Pasupuleti; Björn Walse; Matthias Mörgelin; Anna Chalupka; Martin Malmsten; Artur Schmidtchen
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

Review 8.  Intestinal barrier in inflammatory bowel disease.

Authors:  Lena Antoni; Sabine Nuding; Jan Wehkamp; Eduard F Stange
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

9.  FAD-I, a Fusobacterium nucleatum Cell Wall-Associated Diacylated Lipoprotein That Mediates Human Beta Defensin 2 Induction through Toll-Like Receptor-1/2 (TLR-1/2) and TLR-2/6.

Authors:  Sanghamitra Bhattacharyya; Santosh K Ghosh; Bhumika Shokeen; Betty Eapan; Renate Lux; Janna Kiselar; Stanley Nithianantham; Andrew Young; Pushpa Pandiyan; Thomas S McCormick; Aaron Weinberg
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

10.  Management of Staphylococcus Mediated Systemic Infection by Enhancing the Resurging Activity of Co-trimoxazole in Presence of Cryptdin-2.

Authors:  Amrita Kaur; Shiv Kumar Chabba; Ujjwal Jit Kaur; Arashdeep Kaur; Simran Preet; Praveen Rishi
Journal:  Indian J Microbiol       Date:  2017-09-09       Impact factor: 2.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.